NR2F1 and Bosch-Boonstra-Schaaf optic atrophy syndrome: Overall, the high clinical heterogeneity of BBSOAS patients could be a direct consequence of a yet not well characterized genotype–phenotype correlation, in which specific NR2F1 variants trigger respective clinical outcomes.